Journal Abbreviation: BLOOD CANCER J Journal ISSN: 2044-5385 YearImpact Factor (IF)Total ArticlesTotal Cites 2023 (2024 update)12.9876925 202212.8-6523 20219.812-5662 202011.037874691 20198.023652800 20187.895692247 20178.125581804 20166.126541270 20154.41156790 ...
Pediatric Blood & Cancer Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 1545-5009.
Find pioneering research in Blood Cancer Journal, an open access journal with special collections, 12.9 Impact Factor and 6 days to first decision.
This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years ...
Journal of Medicine.30Speakers at the educational sessions at major society meetings (American Society of Hematology, American Society of Clinical Oncology, European Hematology Association) should also fall under these rules. These individuals exert an extraordinary influence over how cancer is treated ...
英文简介 : Blood Cancer Journal seeks to publish articles of the highest quality related to hematologic malignancies and related disorders. The Journal will consider for publication original research, reviews, guidelines and letters that are considered to be of high impact in the field. Topics of pa...
This journal has been indexed by ESCI and is planned to be indexed by SCIE, with an expected high impact factor. 《血癌发现》是由美国癌症研究学会(AACR)出版的国际同行评审期刊,专注于血液系统疾病的基础、转化和临床研究。该期刊旨在发表在血液病领域具有重大发现及较大影响力的研究内容,推动血液病研究...
impact in the field of hematology, promoting progress in hematology research and communication. The editorial team of the journal is led by internationally authoritative experts in the fields of blood and cancer research, and is composed of renowned experts from top medical research institutions around...
Anup Joseph Devasia Ajai Chari Guido Lancman Blood Cancer Journal(2024) Just scratching the surface: novel treatment approaches for multiple myeloma targeting cell membrane proteins Paola Neri Noémie Leblay Kenneth C. Anderson Nature Reviews Clinical Oncology...
(n = 1123). At diagnosis, the median age was 65 years and with male predominance (3:2) and is comparable to US census data where the median age was reported to be 68 years (https://www.cancer.org/cancer/acute-myeloid-leukemia/about.html,https://seer.cancer.gov/statfacts/html/...